Phylogeny, Inc.

Phylogeny, Inc. provides the highest-quality 35-S labeled and digoxigenin (DIG) labeled in situ hybridization (ISH) service available to the scientific community.
In situ hybridization requires many years of experience to perform and interpret the results accurately; we provide not only validated results but also expert annotation and interpretation of the gene expression labeling.

Activity:

- Contract Research
- Research & Development
- Other Industry Services

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics
- Reagents
- Technology

Therapeutic targets:

- Alzheimer's Disease
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Diabetes
- Neurology
- Oncology
- Reproductive Health
- Urology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Near/Middle East , Australia/New-Zealand , Asia

c. Countries active: USA, Germany, UK

Corporate data:

Number of Employees: 15

Turnover:

Amount:	Year:	Currency:
0	2002	US Dollar

Year founded: 1996